Body

Studies of mutated protein in Lou Gehrig’s disease reveal new paths for drug discovery

PHILADELPHIA -- Several genes have been linked to ALS, with one of the most recent called FUS. Two new studies in PLoS Biology, one from the University of Pennsylvania School of Medicine, and the other from colleagues at Brandeis University, both examined FUS biology in yeast and found that defects in RNA biology may be central to how FUS contributes to ALS, or Lou Gehrig's disease. These findings point to new targets for developing drugs.

Researchers at Brandeis University make strides in understanding amyotrophic lateral sclerosis

Brandeis researchers have made a significant advance in the effort to understand amyotrophic lateral sclerosis (ALS) by successfully reversing the toxicity of the mutated protein in the familial type of the disease.

Transferring doctors to heart attack patients improves outcomes

In a large, traffic-congested city in China, severe heart attack patients received treatment faster and had better long-term results when interventional physicians were taken to them, according to a study in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

The REVERSE-STEMI study involved 334 patients who had suffered a ST elevation myocardial infarction (STEMI), a severe form of heart attack.

Vitamin E or metformin may not be effective for treating liver disease in children and teens

In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.

Medication nonadherence patterns among children with epilepsy associated with socioeconomic status

An examination of medication adherence among children with newly diagnosed epilepsy found that nearly 60 percent showed persistent nonadherence during the first 6 months of therapy, and that lower socioeconomic status was associated with higher non-adherence, according to a study in the April 27 issue of JAMA.

Low health literacy associated with higher rate of death among heart failure patients

An examination of health literacy (such as understanding basic health information) among managed care patients with heart failure, a condition that requires self-management, found that nearly one in five have low health literacy, which was associated with a higher all-cause risk of death, according to a study in the April 27 issue of JAMA.

Increase in evidence-based treatments followed by decreased risk of death in heart attack patients

In an analysis of data from a coronary care registry in Sweden, between 1996-2007 there was an increase in the prevalence of use of evidence-based invasive procedures and pharmacological therapies for treatment of a certain type of heart attack, and a decrease in the rate of death at 30 days and one year after a heart attack for these patients, according to a study in the April 27 issue of JAMA.

Activation of biomarker linked with improved survival among obese patients with colorectal cancer

Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.

Will minorities be left out of health care law provision?

Hospitals and physician practices that form care-coordinating networks called "Accountable Care Organizations (ACOs)," under provisions of the new health-care law could reap cost-savings and other benefits. However, experts at Johns Hopkins and the University of Pennsylvania warn that such networks could potentially be designed to exclude minorities and widen disparities in health care.

Canadians should demand commitments for pharmacare program, says CMAJ

OTTAWA, ONTARIO, CANADA — Canada needs a national pharmacare program and federal leaders must commit adequate funding, states an editorial in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.110643.

Unlike many countries in Europe and Australia and New Zealand, Canada lacks a national pharmacare program that provides consistent coverage across all regions of the country. Currently, drugs that are covered in some provinces may not be in others.

Prey-tell: Why right whales linger in the Gulf of Maine

As they might with most endangered animals, scientists consider the whereabouts and activities of right whales extremely important. "It is helpful to know where they go, why they go there and what they do when they're there," says Mark F. Baumgartner of the biology department at the Woods Hole Oceanographic Institution (WHOI).

Evidence of medical complicity in torture at Guantánamo Bay

Inspection of medical records, case files, and legal affidavits provides compelling evidence that medical personnel who treated detainees at Guantánamo Bay (GTMO) failed to inquire and/or document causes of physical injuries and psychological symptoms they observed in the detainees, according to a paper published this week in PLoS Medicine. Vincent Iacopino, Senior Medical Advisor for Physician for Human Rights, and Brigadier General (Ret) Stephen Xenakis, U.S.

RAD-tagging technology is demystifying genome sequencing

EUGENE, Ore. -- (April 26, 2011) -- Take millions of puzzle pieces containing partial words and put them back together into full words, sentences, paragraphs and chapters until the book these random parts came from is rebuilt.

UCSB scientists discover new drug target for kidney disease

(Santa Barbara, Calif.) -- Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.

Fitness and frailty in adults linked to health outcomes

News Release Embargoed until Monday, April 26, 2011, noon EDT.Please credit CMAJ, not the Canadian Medical Association. CMAJ is an independent medical journal; views expressed here do not necessarily reflect those of its owner, the CMA.